Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
IDEAYA Biosciences logo — Synthetic lethality precision medicine oncology company purs...

IDEAYA Biosciences

Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision medicine targets.

Founded 2015 United States South San Francisco, United States 264 employees Post-IPO Equity Total: $694.10M Biotechnology, Health Care +1

General Information

Company Name IDEAYA Biosciences
Founded Year 2015
Location United States South San Francisco, United States
Founders / Decision Makers
Team member Team member Team member
Employees 264
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with IDEAYA Biosciences. To contact IDEAYA Biosciences, visit ideayabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does IDEAYA Biosciences compare?

A PDF of IDEAYA Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting IDEAYA Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About IDEAYA Biosciences

IDEAYA Biosciences is a biotechnology and healthcare startup founded in 2015, with its headquarters in South San Francisco, California. The company focuses on oncology and precision medicine, aiming to develop targeted therapeutics utilizing molecular diagnostics for patient selection. Their primary focus is on synthetic lethality, an emerging class of precision medicine targets.

IDEAYA recently secured a significant $125.00M Post-IPO Equity investment on 24 October 2023, indicating investor confidence in the company's approach and potential. With a commitment to pioneering first-in-class and/or best-in-class therapeutics, IDEAYA Biosciences is positioned to make a significant impact within the oncology and precision medicine space.

Business keywords: Precision Medicine, Oncology, Synthetic Lethality, Therapeutics, DNA Damage and Repair, Immunotherapy Response, Immuno-Oncology, Targeted Therapeutics, Molecular Diagnostics, Small Molecule Drug Discovery, Cancer Biology, Patient Populations, Headquarters in South San Francisco, Breakthrough Medicines

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $263.00M -
09 Jul 2024
Post IPO Equity $125.00M -
24 Oct 2023
Post IPO Equity $80.00M -
14 Sep 2022
Post IPO Equity $86.10M -
07 Jul 2021
Series B $94.00M 10
Canaan Partners GV WuXi Healthcare Ventures
Canaan Partners, GV +8
15 Mar 2018
Series A $46.00M 6
Canaan Partners 5AM Ventures WuXi Healthcare Ventures
Canaan Partners, 5AM Ventures +4
03 May 2016
Seed Round Undisclosed 1
5AM Ventures
5AM Ventures
01 Jan 2015

IDEAYA Biosciences Alternatives & Competitors

View All Alternatives
IDEAYA Biosciences vs
Tango Therapeutics
Tango Therapeutics United States

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medic...

Post-IPO Equity
182 employees
Biotechnology, Health Care
Compare IDEAYA Biosciences vs Tango Therapeutics
IDEAYA Biosciences vs
Synnovation Therapeutics
Synnovation Therapeutics United States

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
Compare IDEAYA Biosciences vs Synnovation Therapeutics
IDEAYA Biosciences vs
SyntheX
SyntheX United States

Targeting the undruggable with synthetic biology-based drug discovery platforms

Venture round
26 employees
Biotechnology, Health and Wellness
Compare IDEAYA Biosciences vs SyntheX
View all alternatives

FAQ About IDEAYA Biosciences

Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision medicine targets.
IDEAYA Biosciences was founded in 2015.
IDEAYA Biosciences is headquartered in South San Francisco, United States.
IDEAYA Biosciences operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Precision Medicine, Oncology, Synthetic Lethality and Therapeutics.
IDEAYA Biosciences has approximately 264 employees.
IDEAYA Biosciences has completed 7 funding rounds, raising a total of $694.10M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to IDEAYA Biosciences include Tango Therapeutics, Synnovation Therapeutics, SyntheX, Tempest Therapeutics, Breakpoint Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IDEAYA Biosciences and Tango Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for IDEAYA Biosciences, https://bouncewatch.com/company/ideaya-biosciences, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout